Several successfully completed clinical trials of novel therapies in glomerular disease were reported in 2023. Building on important mechanistic discoveries about disease onset and progression over the past several years, these therapies raise hope that multiple options will be available to reduce the risk of kidney failure in glomerular disease.

中文翻译：

---

获得肾小球疾病机制发现的回报

2023 年报道了几项成功完成的肾小球疾病新疗法的临床试验。基于过去几年有关疾病发作和进展的重要机制发现，这些疗法带来了希望，即有多种选择可以降低肾小球疾病的肾衰竭风险。肾小球疾病。